US 11,998,324 B2
Biomarker monitoring fitness system
Harold Philpott Southerland, III, Atlanta, GA (US); Todd Furneaux, Atlanta, GA (US); Juan Pablo Frias, Atlanta, GA (US); and Roger Steven Mazze, Excelsior, MN (US)
Assigned to TT1 Products, Inc., Atlanta, GA (US)
Filed by TT1 Products, Inc., Atlanta, GA (US)
Filed on Oct. 25, 2021, as Appl. No. 17/509,386.
Application 17/509,386 is a continuation of application No. 17/008,577, filed on Aug. 31, 2020, granted, now 11,154,223.
Claims priority of provisional application 62/894,155, filed on Aug. 30, 2019.
Prior Publication US 2022/0039704 A1, Feb. 10, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 5/145 (2006.01); A61B 5/00 (2006.01); A61B 5/11 (2006.01)
CPC A61B 5/14532 (2013.01) [A61B 5/0004 (2013.01); A61B 5/0024 (2013.01); A61B 5/1112 (2013.01); A61B 5/6801 (2013.01); A61B 5/7292 (2013.01); A61B 5/742 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A computer-implemented method in which one or more processing devices perform operations comprising:
determining a glucose exposure for a particular hour based on glucose data received from a sensor on a particular interval;
determining a target glucose exposure for the particular hour by multiplying a glucose exposure limit per hour by a numerical representation of the particular hour;
receiving additional biomarker data comprising one or more of cardiovascular, pulmonary, and perspiratory data;
integrating the glucose exposure for the particular hour and the additional biomarker data for display; and
displaying the glucose exposure for the particular hour as a proportion of the target glucose exposure for the particular hour and the additional biomarker data on a display.